Cost-effectiveness of community-acquired pneumonia therapy.
Expert Rev Pharmacoecon Outcomes Res
; 3(6): 749-56, 2003 Dec.
Article
em En
| MEDLINE
| ID: mdl-19807352
ABSTRACT
Community-acquired pneumonia is a common disease in adults and substantially contributes to morbidity and mortality in the USA and worldwide. Due to the significant costs associated with this disease, there is increasing pressure to evaluate the variation in practices among healthcare providers. The processes of care related to the diagnosis, management and prevention of community-acquired pneumonia are reviewed. Furthermore, the cost-effective strategies for community-acquired pneumonia and the medical evidence that support their usage are outlined.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Health_economic_evaluation
Idioma:
En
Revista:
Expert Rev Pharmacoecon Outcomes Res
Assunto da revista:
FARMACOLOGIA
Ano de publicação:
2003
Tipo de documento:
Article
País de afiliação:
Estados Unidos